PT Pelayaran Tamarin Samudra Tbk (IDX:TAMU)

Verve Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2.66	3.9	2.39	2.25	1.21	2.61
Cash & Short-Term Investments	2.66	3.9	2.39	2.25	1.21	2.61
Cash Growth	19.54%	63.50%	5.83%	86.91%	-53.85%	72.67%
Accounts Receivable	4.08	3.57	3.54	3.29	3.62	3.37
Other Receivables	5.5	4.53	5.39	3.61	3.69	1.89
Receivables	9.58	8.1	8.93	6.9	7.32	5.25
Prepaid Expenses	0.08	0.07	0.28	0.21	0.08	0.2
Other Current Assets	0.35	0.01	0.38	0.34	0.45	0.34
Total Current Assets	12.67	12.08	11.98	9.7	9.06	8.41
Property, Plant & Equipment	18.89	19.57	41.59	51.28	58.25	67.99
Long-Term Deferred Tax Assets	0.64	0.64	1.12	0.71	0.72	0.75
Other Long-Term Assets	2.31	2.27	1.51	1.48	2.61	4.87
Total Assets	34.51	34.57	56.2	63.18	70.64	82.02
Accounts Payable	0.33	0.35	2.02	0.73	0.29	0.83
Accrued Expenses	0.13	0.01	1.02	0.43	0.27	0.43
Short-Term Debt	-	-	-	-	-	0.68
Current Portion of Long-Term Debt	1.69	2.05	6.6	4.76	3.35	3.7
Current Income Taxes Payable	0	0	0	0	0	0
Other Current Liabilities	0	0	0.24	0.23	0.63	-
Total Current Liabilities	2.16	2.41	9.88	6.16	4.55	5.64
Long-Term Debt	12.48	12.42	16.07	22.28	27.46	35.13
Other Long-Term Liabilities	1.2	1.12	4.24	3.74	2.74	0.82
Total Liabilities	15.91	16.01	30.26	32.25	34.85	41.81
Common Stock	30.11	30.11	30.11	30.11	30.11	30.11
Additional Paid-In Capital	0.31	0.31	0.31	0.31	0.31	0.31
Retained Earnings	-11.92	-11.96	-4.57	0.43	5.31	9.74
Comprehensive Income & Other	0.09	0.09	0.08	0.07	0.06	0.05
Total Common Equity	18.6	18.55	25.94	30.93	35.79	40.21
Minority Interest	0	0	0	0	0	0
Shareholders' Equity	18.6	18.55	25.94	30.93	35.79	40.21
Total Liabilities & Equity	34.51	34.57	56.2	63.18	70.64	82.02
Total Debt	14.18	14.47	22.67	27.04	30.81	39.51
Net Cash (Debt)	-11.52	-10.57	-20.28	-24.78	-29.61	-36.9
Net Cash Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Filing Date Shares Outstanding	37,500	37,500	37,500	37,500	37,500	37,500
Total Common Shares Outstanding	37,500	37,500	37,500	37,500	37,500	37,500
Working Capital	10.51	9.67	2.1	3.54	4.51	2.77
Book Value Per Share	0.00	0.00	0.00	0.00	0.00	0.00
Tangible Book Value	18.6	18.55	25.94	30.93	35.79	40.21
Tangible Book Value Per Share	0.00	0.00	0.00	0.00	0.00	0.00
Land	-	0.99	0.99	0.99	0.99	0.99
Machinery	-	76.1	119.31	122.28	122.07	125.28
Construction In Progress	-	-	-	-	-	1.25
Leasehold Improvements	-	0.1	0.1	0.1	0.1	0.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.